Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. - Wikidata - awgldk - TriplyDB

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability.

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability.

http://www.wikidata.org/entity/Q43243004

about

Zinc diet and Alzheimer's disease: a systematic review Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases Role of environmental contaminants in the etiology of Alzheimer's disease: a review Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts Regional specific groundwater arsenic levels and neuropsychological functioning: a cross-sectional study.Biological consequences of zinc deficiency in the pathomechanisms of selected diseases.Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold.Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer's Disease Cases than in Controls: A Series of Meta-Analyses.Distinctive Pattern of Serum Elements During the Progression of Alzheimer's Disease.Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.Zinc homeostasis and neurodegenerative disorders Differences in trace metal concentrations (Co, Cu, Fe, Mn, Zn, Cd, And Ni) in whole blood, plasma, and urine of obese and nonobese children Serum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease.Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment.Association of Serum Manganese Levels with Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis Metal attenuating therapies in neurodegenerative disease.The role of metallobiology and amyloid-β peptides in Alzheimer's disease.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease.Characterization of biometal profiles in neurological disorders.Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies.Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression.Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo.Alzheimer's disease causation by copper toxicity and treatment with zinc.The role of zinc in Alzheimer's disease.Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses Protective effects of copper against aluminum toxicity on acetylcholinesterase and catecholamine contents of different regions of rat's brain.Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease.Evaluation of a prototype point-of-care instrument based on monochromatic x-ray fluorescence spectrometry: potential for monitoring trace element status of subjects with neurodegenerative disease.Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.Homeostasis of metals in the progression of Alzheimer's disease.Characterization of metal profiles in serum during the progression of Alzheimer's disease.The role of astrocytes in amyloid production and Alzheimer's disease.Flow of essential elements in subcellular fractions during oxidative stress.Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease.

P2860

Q22241775-12A2FC2B-1209-459E-858E-4315D32DEDA6 Q22252920-883323EE-A9DA-4FD1-AD49-4E8AC734F786 Q26765782-686677C8-93C4-4545-B51F-E5B36CC220B6 Q26821835-C3532139-3ECE-4A82-ABE9-2351AB7CD710 Q26830320-FA6FA8FA-AF8A-4E36-B92F-7F5420DDFC12 Q28387541-37927904-7686-4EA1-A9B8-D2120CFB88D2 Q34017338-06B5BD32-492A-46AC-99B7-7ACB3585E450 Q34243472-348C314A-DA8B-4476-B157-C25C3D704242 Q35290019-28ABAF92-8B7E-4C79-B9D5-40695093EB9D Q35561700-C3D3C76E-8C34-46D4-9206-2A2108D42DF6 Q35786345-AA601BFE-3AFE-433D-AEE2-BDC26B446879 Q36666749-B34054AB-C96B-4843-B979-33B239BD02BA Q36939873-6654CBBB-8677-4077-9731-984DF66A3346 Q37025484-721B6D22-80B0-43CA-883C-94514A3B867A Q37203779-6C1C2217-D3DF-4976-AD03-237FB85F5C25 Q37224163-C7F164D9-8D18-4B4E-B7FC-A32117485834 Q37569276-B0610DEC-3C46-495B-918A-313CB092A51D Q37729700-F1A4BF35-A9BE-48E8-B017-D8B0C8975030 Q37957126-8969FB1F-9D63-4D7E-B1A0-6092CC4CD1CD Q37961769-E21C0487-B83E-4A44-BF32-437C57AD751C Q38125769-BB50C6DE-A0E1-4445-8A70-5B77B94A4AC7 Q38162228-D8E3CD7A-2907-428C-A226-EC1DEDF9396E Q38197094-EC0C746D-92AD-49B0-9CFF-6FDB4C3A4DFB Q38362089-5D595F17-FD22-4775-937E-1304CC220100 Q38763381-F2A9F4D1-0F2A-4AE5-919F-EE7C13612D7E Q39359977-9638E118-B29B-4012-B320-D84BDA10C380 Q39851388-FB1F4F8A-C5E3-45FF-A723-566D0C27031A Q41488419-CA5F1CB7-060A-4566-9595-D2566D744664 Q42019923-92745834-45A6-4576-8708-957C1BC6644A Q42655692-9A8F9C1D-7B21-4204-87CC-C97BB61249B0 Q42713220-5D76CDC8-5DE2-4ED5-AF26-61DC1EFA2489 Q42791835-3F4746FA-702E-493F-9CCB-AEF5D989BA05 Q42907418-0A1228AF-7CAA-4EBE-824A-3F00EA679588 Q43551249-BA1F2561-1EFF-4EFA-808B-C18088AF4635 Q46458603-F7883F8F-1514-43B9-B11E-BAC68473A9D1 Q46914412-B66202F2-A742-4C61-A4CF-9BDFE6821464 Q46958881-B5B68CFA-8FEA-412F-BB33-891CE9BD9340 Q47296419-6FAF0710-B917-4B28-8282-A17A7FC441B9 Q47591045-0343856E-D495-4126-8150-A28B44BFB239 Q48257794-647D49C0-53C4-448A-B92F-F78B4565E7E0

P2860

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability.

http://www.wikidata.org/entity/Q43243004

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@en

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@nl

type

label

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@en

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@nl

prefLabel

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@en

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@nl

P1433

Q43243004-9D6C799F-4259-4C4B-90C9-6F90923E1D2B

P1476

Q43243004-C41584B9-090C-45D7-A403-6A48608068EB

P2093

Q43243004-05088F52-992C-453D-BFFF-1DB1F82856CE

Q43243004-4253B8E8-3027-4763-B0A9-717B82E4C4A4

Q43243004-5EE8706D-5AAC-4F3C-BE25-07938EDCC304

Q43243004-69E4EE48-40F0-4AA0-8BFF-624C5C58860F

Q43243004-6D32D0E0-BD14-4679-80CC-D42A514F2711

Q43243004-8496468B-578F-436D-BE33-448E95AC94E3

Q43243004-98EF21A3-5B34-4C16-8A9D-5D8769110905

Q43243004-9DE44E18-3B6D-4D7A-AFFB-3A45DEEFDD03

Q43243004-AF3C77D8-377B-4ED7-872F-F09526235D18

Q43243004-B300F1E7-2FCA-43F3-9E16-5D85C8E87743

P2860

Q43243004-160CE8D1-3CF5-4FD6-89DF-6A943FA6C67A

P2888

Q43243004-2331C73A-FE60-4B7C-813C-1C5A51D4286E

P304

Q43243004-7178D2C4-15C7-4EDF-BC64-A55955087A0A

P31

Q43243004-BD794A94-F812-4638-B643-1AE049BF9878

P356

Q43243004-7B3A0A73-6BA1-4E4C-A1A8-50289F680A52

P433

Q43243004-EBDDE5DE-4422-489A-A9BC-6ABA72BD2A5C

P478

Q43243004-7A052B1E-E277-4C85-9E05-814881C5EF43

P50

Q43243004-034D62F9-B3E3-4C41-8C2C-9E8A440DFEBF

Q43243004-4AE691EF-4583-418D-8DB4-50DBF8EE524A

Q43243004-6820C6E7-F3AE-4171-B2CF-8F994C6D9325

Q43243004-B0D952CC-EF3D-41CB-8E5E-99AECB8BC075

Q43243004-B6FB0360-E97E-43BE-8CF4-E2DFBCBDE5FD

Q43243004-C661DABD-8D4B-4B6E-9D34-47454EDA6AA8

P577

Q43243004-C53D6B3E-E911-4993-A4D0-ADFCE4D0A1E5

P5875

Q43243004-83DFAA2E-D54E-412A-917F-3C3131F0F9B4

P6179

Q43243004-8EDEAA55-5309-4C60-8513-9F5B168C657B

P698

Q43243004-4DEB8985-F068-485F-BB55-AD4363B1B442

P921

Q43243004-9AF1A035-7166-4BD0-BA3B-A6D44526BD40

P356

S10534-009-9277-5

P1433

P1476

Serum zinc is decreased in Alz ...... tively with cognitive ability.

@en

P2093

Chelsia Ng

http://www.w3.org/2001/XMLSchema#string

Christopher Wai Kei Lam

http://www.w3.org/2001/XMLSchema#string

Elsie Hui

http://www.w3.org/2001/XMLSchema#string

Helen Fung Kum Chiu

http://www.w3.org/2001/XMLSchema#string

Iris Hiu Shuen Chan

http://www.w3.org/2001/XMLSchema#string

Joshua Tsoh

http://www.w3.org/2001/XMLSchema#string

Ming-Houng Chan

http://www.w3.org/2001/XMLSchema#string

Samuel Szeto

http://www.w3.org/2001/XMLSchema#string

Stanley Kwok-Kuen Cheung

http://www.w3.org/2001/XMLSchema#string

Timothy Kwok

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

P2888

s10534-009-9277-5

P304

173-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10534-009-9277-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Benny Chung-Ying Zee

P577

2009-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38087195

http://www.w3.org/2001/XMLSchema#string

P6179

1016609121

http://www.w3.org/2001/XMLSchema#string

P698

19911117

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease